Glenmark Pharmaceuticals Limited (GLENMARK.NS) NSE

1,965.10

-6.6(-0.33%)

Updated at September 29 02:39PM

Currency In INR

Valuation

Market Cap425.84B
Enterprise Value433.81B
P/E Ratio73.46
PEG Ratio-2.62
Price/Sales Ratio4.25
Price/Book Ratio6.26
Enterprise/Revenue4.31
Enterprise/EBITDA31.96

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.06
Operating Margin0.14

Management Effectiveness

Return On Assets0.05
Return On Equity0.09

Income Statement

Revenue134.35B
Revenue/Share461.46
Gross Profit54.6B
EBITDA20.92B
Net Income10.47B
Diluted EPS37.11

Balance Sheet

Total Cash17.68B
Total Cash/Share62.6
Total Debt24.73B
Total Debt/Equity0.28
Current Ratio1.56
Book Value Per Share313.4

Price History

52-Week Change17.17
52-Week High2,284.8
52-Week Low1,275.5
Moving Average 50 Days2,045.02
Moving Average 200 Days1,653.3

Statistics

Average Volume1.23M
Shares Outstanding282.2M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate2.5
Trailing Annual Dividend Yield0.13
Payout Ratio0
Last Split Factor2:1
Last Split DateSeptember 10, 2007